Phosphotyrosine interactome of the ErbB‐receptor kinase family

Schulze, Waltraud X, Deng, Lei, Mann, Matthias·2005·Molecular Systems Biology

Cited by (754)

Items 201–300 of 754

  1. Exact model reduction of combinatorial reaction networks
    H. Conzelmann, Dirk Fey, Ernst Dieter Gilles · 2008 · BMC Systems Biology
  2. Bimolecular complementation affinity purification (BiCAP) reveals dimer-specific protein interactions for ERBB2 dimers
    David R. Croucher, Mary Iconomou, Jordan F. Hastings, Sean P. Kennedy, Jeremy Z. R. Han, Robert F. Shearer, Jessie A. McKenna, Adrian Wan, Joseph Lau, Samuel A. J. R. Aparicio et al. · 2016 · Science Signaling
  3. HER2 stabilizes EGFR and itself by altering autophosphorylation patterns in a manner that overcomes regulatory mechanisms and promotes proliferative and transformation signaling
    Zachary Hartman, Hua Zhao, Yehenew M. Agazie · 2012 · Oncogene
  4. Proteins associated with pancreatic cancer survival in patients with resectable pancreatic ductal adenocarcinoma
    Chen, Ru, Dawson, David W, Pan, Sheng, Ottenhof, Niki A, de Wilde, Roeland F, Wolfgang, Christopher L, May, Damon H, Crispin, David A, Lai, Lisa A, Lay, Anna R et al. · 2015 · Laboratory Investigation
  5. Copine-III interacts with ErbB2 and promotes tumor cell migration
    Constanze Heinrich, C Keller, Anne Boulay, Manuela Vecchi, M Bianchi, Ragna Sack, Susanne Lienhard, Stephan Duss, Jan Hofsteenge, Nancy E. Hynes · 2009 · Oncogene
  6. The inhibition of epidermal growth factor receptor signaling by hexagonal selenium nanoparticles modified by SiRNA
    L Kamrani Moghaddam, S Ramezani Paschepari, Mohammad Ali Zaimy, A Abdalaian, Ali Jebali · 2016 · Cancer Gene Therapy
  7. Molecular Pathways and Mechanisms of HER2 in Cancer Therapy
    Kanwal P. S. Raghav, Mark M. Moasser · 2022 · Clinical Cancer Research
  8. Characterization of the EGFR interactome reveals associated protein complex networks and intracellular receptor dynamics
    Sarah Foerster, Tim Kacprowski, Vishnu Mukund Dhople, Elke Hammer, Susann Herzog, Hisham Saafan, Sandra Bien-Möller, Mario Albrecht, Uwe Völker, Christoph Alexander Ritter · 2013 · PROTEOMICS
  9. Structure-based virtual screening and molecular docking for the identification of potential multi-targeted inhibitors against breast cancer
    Zeeshan Yousuf, Kanzal Iman, Nouman Iftikhar, Muhammad Usman Mirza · 2017 · Breast Cancer Targets and Therapy
  10. Introduction to Systems Biology
    Bin Hu, Pawan Kumar Dhar · 2014 · Springer eBooks
  11. Sometimes the Result Is Not the Answer: The Truths and the Lies That Come From Using the Complementation Test
    R. Scott Hawley, William D Gilliland · 2006 · Genetics
  12. Cryptochrome Antagonizes Synchronization of Drosophila’s Circadian Clock to Temperature Cycles
    Carla Gentile, Hana Sehadová, Alekos Simoni, Chenghao Chen, Ralf Stanewsky · 2013 · Current Biology
  13. Temporal Perturbation of Tyrosine Phosphoproteome Dynamics Reveals the System-wide Regulatory Networks
    Masaaki Oyama, Hiroko Kozuka‐Hata, Shinya Tasaki, Kentaro Semba, Seisuke Hattori, Sumio Sugano, Jun-ichiro Inoue, Tadashi Yamamoto · 2008 · Molecular & Cellular Proteomics
  14. Human Prostatic Acid Phosphatase, an Authentic Tyrosine Phosphatase, Dephosphorylates ErbB-2 and Regulates Prostate Cancer Cell Growth
    Tsai‐Der Chuang, Siu-Ju Chen, Fen‐Fen Lin, Suresh Veeramani, Satyendra Kumar, Surinder K. Batra, Yaping Tu, Ming‐Fong Lin · 2010 · Journal of Biological Chemistry
  15. High-throughput methods for identification of protein-protein interactions involving short linear motifs
    Cecilia Blikstad, Ylva Ivarsson · 2015 · Cell Communication and Signaling
  16. Early clinical development of epidermal growth factor receptor targeted therapy in breast cancer
    Naoko Matsuda, Bora Lim, Xiaoping Wang, Naoto Tada Ueno · 2017 · Expert Opinion on Investigational Drugs
  17. The Yeast Saccharomyces cerevisiae as a Model for Understanding RAS Proteins and their Role in Human Tumorigenesis
    Giulia Cazzanelli, Flávia Dayana Silva Pereira, Sara Alves, Rita Francisco, Luı́sa Azevedo, Patrícia Dias Carvalho, Ana F. Almeida, Manuela Côrte‐Real, María José Oliveira, Cândida Lucas et al. · 2018 · Cells
  18. Phosphorylation-Specific MS/MS Scoring for Rapid and Accurate Phosphoproteome Analysis
    Samuel Payne, Margaret Y. Yau, Marcus Bustamante Smolka, Stephen W. Tanner, Huilin Zhou, Vineet Bafna · 2008 · Journal of Proteome Research
  19. An Extensive Survey of Tyrosine Phosphorylation Revealing New Sites in Human Mammary Epithelial Cells
    Tyler H. Heibeck, Shi‐Jian Ding, Lee K. Opresko, Rui Zhao, Athena Schepmoes, Feng Yang, Aleksey V. Tolmachev, Matthew E Monroe, David Camp, Richard D. Smith et al. · 2009 · Journal of Proteome Research
  20. Live cell fluorescence imaging reveals high stoichiometry of Grb2 binding to the EGF receptor sustained during endocytosis
    Arola Fortian, Alexander D. Sorkin · 2013 · Journal of Cell Science
  21. Receptor tyrosine kinase signaling: a view from quantitative proteomics
    Jörn Dengjel, Irina Kratchmarova, Blagoy Blagoev · 2009 · Molecular BioSystems
  22. Spatio-temporal modeling of signaling protein recruitment to EGFR
    Ming-yu Hsieh, Shujie Yang, Mary Ann Raymond‐Stintz, Jeremy S. Edwards, Bridget Smith Wilson · 2010 · BMC Systems Biology
  23. Emerging anti-cancer antibodies and combination therapies targeting HER3/ERBB3
    Nadège Gaborit, Moshit Lindzen, Yosef Yarden · 2015 · Human Vaccines & Immunotherapeutics
  24. CIRCADIAN CLOCK ASSOCIATED1 Transcript Stability and the Entrainment of the Circadian Clock in Arabidopsis
    Esther Yakir, Dror Hilman, Miriam Hassidim, Rachel M. Green · 2007 · PLANT PHYSIOLOGY
  25. N-glycans of growth factor receptors: their role in receptor function and disease implications
    Motoko Takahashi, Yoshihiro Hasegawa, Congxiao Gao, Yoshio Kuroki, Naoyuki Taniguchi · 2016 · Clinical Science
  26. Hydra: a scalable proteomic search engine which utilizes the Hadoop distributed computing framework
    Steven Lewis, Attila Csordás, Sarah Killcoyne, Henning Hermjakob, Michael R. Hoopmann, Robert L. Moritz, Eric W. Deutsch, John Boyle · 2012 · BMC Bioinformatics
  27. Reconstruction and logical modeling of glucose repression signaling pathways in Saccharomyces cerevisiae
    Tobias S. Christensen, Ana Paula Oliveira, Jens Nielsen · 2009 · BMC Systems Biology
  28. PP2A-3 interacts with ACR4 and regulates formative cell division in the Arabidopsis root
    Kun Yue, Priyanka Sandal, Elisabeth L. Williams, Evan Murphy, Elisabeth Stes, Natalia Nikonorova, Priya Ramakrishna, Nathan Czyzewicz, Laura Montero‐Morales, Robert P. Kumpf et al. · 2016 · Proceedings of the National Academy of Sciences
  29. Towards functional phosphoproteomics by mapping differential phosphorylation events in signaling networks
    Sergio de la Fuente van Bentem, Wieslawa I. Mentzen, Alberto de la Fuente, Heribert Hirt A · 2008 · PROTEOMICS
  30. Function-Blocking ERBB3 Antibody Inhibits the Adaptive Response to RAF Inhibitor
    Curtis H. Kugel, Edward J. Hartsough, Michael A. Davies, Yulius Y. Setiady, Andrew E. Aplin · 2014 · Cancer Research
  31. Unraveling trastuzumab and lapatinib inefficiency in gastric cancer: Future steps (Review)
    Shouji Shimoyama · 2013 · Molecular and Clinical Oncology
  32. Therapeutic targeting of erbB3 with MM-121/SAR256212 enhances antitumor activity of paclitaxel against erbB2-overexpressing breast cancer
    Shuiliang Wang, Jingcao Huang, Hui Lyu, Bo Cai, Xiaoping Yang, Fang Li, Ming Jen Tan, Susan M. Edgerton, Ann D. Thor, Choon‐Kee Lee et al. · 2013 · Breast Cancer Research
  33. Analysis of transient phosphorylation-dependent protein-protein interactions in living mammalian cells using split-TEV
    Michael C. Wehr, Lisa Reinecke, Anna Botvinnik, Moritz J. Rossner · 2008 · BMC Biotechnology
  34. Signaling of ERBB receptor tyrosine kinases promotes neuroblastoma growth in vitro and in vivo
    Kristen N. Richards, Patrick A. Zweidler‐McKay, Nadine Van Roy, Frank Speleman, Jesus Trevino, Peter E. Zage, Dennis P.M. Hughes · 2010 · Cancer
  35. Advances in Targeting HER3 as an Anticancer Therapy
    Ning Jiang, Nabil F. Saba, Zhuo Georgia Chen · 2012 · Chemotherapy Research and Practice
  36. Beyond the Biomarker: Understanding the Diverse Roles of Human Epididymis Protein 4 in the Pathogenesis of Epithelial Ovarian Cancer
    Nicole E. James, Clinton O. Chichester, Jennifer R. Ribeiro · 2018 · Frontiers in Oncology
  37. The Adaptor Proteins p66Shc and Grb2 Regulate the Activation of the GTPases ARF1 and ARF6 in Invasive Breast Cancer Cells
    Eric Haines, Caroline Saucier, Audrey Claing · 2014 · Journal of Biological Chemistry
  38. Proteomics and phosphoproteomics for the mapping of cellular signalling networks
    Christian Preisinger, Alex von Kriegsheim, David Matallanas, Walter Kölch · 2008 · PROTEOMICS
  39. Positive and Negative Symptoms in Schizophrenia: The NMDA Receptor Hypofunction Hypothesis, Neuregulin/ErbB4 and Synapse Regression
    Maxwell R. Bennett · 2009 · Australian & New Zealand Journal of Psychiatry
  40. Chapter Six - The Ubiquitin Network in the Control of EGFR Endocytosis and Signaling
    Alexia Conte, Sara Sigismund · 2016 · Progress in molecular biology and translational science
  41. Multiple myeloma phosphotyrosine proteomic profile associated with FGFR3 expression, ligand activation, and drug inhibition
    Jonathan R. St‐Germain, Paul P. Taylor, Jiefei Tong, Lily L. Jin, Ana Nikolic, Ian I. Stewart, Rob M. Ewing, Moyez Dharsee, Zhihua Li, Suzanne Trudel et al. · 2009 · Proceedings of the National Academy of Sciences
  42. ERBB oncogene proteins as targets for monoclonal antibodies
    Oleg L. Polanovsky, Ekaterina N. Lebedenko, Sergey Mikhailovich Deyev · 2012 · Biochemistry (Moscow)
  43. Role of erbB3 receptors in cancer therapeutic resistance
    Youngseok Lee, Jian Ma, Hui Lyu, Jingcao Huang, Aeree Kim, Bolin Liu · 2014 · Acta Biochimica et Biophysica Sinica
  44. Degradable Polyethylenimine-Based Gene Carriers for Cancer Therapy
    Hu‐Lin Jiang, Mohammad Ariful Islam, Lei Xing, Jannatul Firdous, Wuji Cao, Yujing He, Yong Zhu, Ki‐Hyun Cho, Hui-Shan Li, Chong‐Su Cho · 2017 · Topics in Current Chemistry
  45. Post-translational modifications at the ATP-positioning G-loop that regulate protein kinase activity
    Susan F. Steinberg · 2018 · Pharmacological Research
  46. Multiscale Cancer Modeling
    Fletcher, Alexander G., Mirams, Gary R., Murray, Philip J., Walter, Alex, Kang, Jun Won, Cho, Kwang Hyun, Maini, Philip K., Helen Mary Byrne · 2010 · CRC Press eBooks
  47. Drosophila EGFR signalling is modulated by differential compartmentalization of Rhomboid intramembrane proteases
    Shaul Yogev, Eyal D. Schejter, Ben‐Zion Shilo · 2008 · The EMBO Journal
  48. MassWiz: A Novel Scoring Algorithm with Target-Decoy Based Analysis Pipeline for Tandem Mass Spectrometry
    Amit Kumar Yadav, Dhirendra Kumar, Debasis Dash · 2011 · Journal of Proteome Research
  49. Atomistic Insights into Regulatory Mechanisms of the HER2 Tyrosine Kinase Domain: A Molecular Dynamics Study
    Shannon Telesco, Ravi Radhakrishnan · 2009 · Biophysical Journal
  50. Dysregulation of the NRG1/ERBB pathway causes a developmental disorder with gastrointestinal dysmotility in humans
    Thuy-Linh Le, Louise Galmiche, Jonathan Lévy, Pim Suwannarat, Debby M.E.I. Hellebrekers, Khomgrit Morarach, Franck Boismoreau, Tom E. J. Theunissen, Mathilde Lefebvre, Anna Pelet et al. · 2021 · Journal of Clinical Investigation
  51. Intermittent Hypoxia Mobilizes Bone Marrow-Derived Very Small Embryonic-Like Stem Cells and Activates Developmental Transcriptional Programs in Mice
    Sina A. Gharib, Ehab A. Dayyat, Abdelnaby Khalyfa, Jinkwan Kim, Heather B. Clair, Magda Kucia, David Gozal · 2010 · SLEEP
  52. Quantification and Kinetic Analysis of Grb2-EGFR Interaction on Micro-Patterned Surfaces for the Characterization of EGFR-Modulating Substances
    Peter Lanzerstorfer, Daniela M. Borgmann, Gerhard J. Schütz, Stephan Winkler, Otmar Höglinger, Julian Weghuber · 2014 · PLoS ONE
  53. Regulation of Cell-to-Cell Communication and Cell Wall Integrity by a Network of MAP Kinase Pathways and Transcription Factors in Neurospora crassa
    Monika S. Fischer, Vincent W. Wu, Ji E. Lee, Ronan C. O’Malley, N. Louise Glass · 2018 · Genetics
  54. An essential role for Argonaute 2 in EGFR-KRAS signaling in pancreatic cancer development
    Sunita Shankar, Jean Ching-Yi Tien, Ronald F. Siebenaler, Seema Chugh, Vijaya L. Dommeti, Sylvia Zelenka-Wang, Jessica J. Waninger, Kristin M. Juckette, Alice Xu, Xiao-Ming Wang et al. · 2020 · Nature Communications
  55. Protein Inhibitor of Activated STAT3 (PIAS3) Protein Promotes SUMOylation and Nuclear Sequestration of the Intracellular Domain of ErbB4 Protein
    Maria Sundvall, Anna Korhonen, Katri Mataleena Vaparanta, Julius Anckar, Kalle Halkilahti, Zaidoun Salah, Rami I. Aqeilan, Jorma J. Palvimo, Lea Sistonen, Klaus Elenius · 2012 · Journal of Biological Chemistry
  56. Phosphotyrosine signaling analysis of site-specific mutations on EGFRvIII identifies determinants governing glioblastoma cell growth
    Paul H. Huang, Emily R. Miraldi, Alexander M. Xu, Vibin A. Kundukulam, Amanda M. Del Rosario, Ryan A. Flynn, Webster K. Cavenee, Frank B. Furnari, Forest M. White · 2010 · Molecular BioSystems
  57. Phosphorylated EGFR expression may predict outcome of EGFR-TKIs therapy for the advanced NSCLC patients with wild-type EGFR
    Fen Wang, Shuhang Wang, Zhijie Wang, Jianchun Duan, Tongtong An, Jun Zhao, Hua Bai, Jie Wang · 2012 · Journal of Experimental & Clinical Cancer Research
  58. Design, synthesis and biological evaluation of novel EGFR/HER2 dual inhibitors bearing a oxazolo[4,5-g]quinazolin-2(1H)-one scaffold
    Siyuan Yin, Chunming Tang, Bin Wang, Ying Zhang, Liliang Zhou, Lingjing Xue, Can Zhang · 2016 · European Journal of Medicinal Chemistry
  59. Deep mutational analysis reveals functional trade-offs in the sequences of EGFR autophosphorylation sites
    Aaron J. Cantor, Neel H. Shah, John Kuriyan · 2018 · Proceedings of the National Academy of Sciences
  60. Extent and context dependence of pleiotropy revealed by high-throughput single-cell phenotyping
    Kerry Geiler‐Samerotte, Shuang Li, Charalampos Lazaris, Austin Taylor, Naomi Ziv, Chelsea Ramjeawan, Annalise B. Paaby, Mark L. Siegal · 2020 · PLoS Biology
  61. Sensitivity of epidermal growth factor receptor and ErbB2 exon 20 insertion mutants to Hsp90 inhibition
    Weiguo Xu, Shiro Soga, Kristen L. Beebe, M-J Lee, Young Shin Kim, Jane B. Trepel, Len Neckers · 2007 · British Journal of Cancer
  62. Quantitative proteomic approaches for studying phosphotyrosine signaling
    Shi‐Jian Ding, Weijun Qian, Richard D. Smith · 2007 · Expert Review of Proteomics
  63. Magnetic Nanoparticles as Mediators of Ligand-Free Activation of EGFR Signaling
    Atul Bharde, Raghavendra Palankar, Cornelia Fritsch, A. Klaver, Johannes Sake Kanger, Thomas M. Jovin, Donna J. Arndt‐Jovin · 2013 · PLoS ONE
  64. Proteomic Dissection of Cell Type-Specific H2AX-Interacting Protein Complex Associated with Hepatocellular Carcinoma
    Xiaoli Yang, Peng Zou, Jun Yao, Dong Yun, Huimin Bao, Ruyun Du, Jing Long, Xian Chen · 2009 · Journal of Proteome Research
  65. Halobacterium salinarum NRC-1 PeptideAtlas: Toward Strategies for Targeted Proteomics and Improved Proteome Coverage
    Phu T. Van, Amy Schmid, Nichole L. King, Amardeep Kaur, Min Pan, Kenia Whitehead, Tie Koide, Marc T. Facciotti, Young Ah Goo, Eric W. Deutsch et al. · 2008 · Journal of Proteome Research
  66. Phosphoproteomics: new insights into cellular signaling.
    Marc C. Mumby, Deirdre L. Brekken · 2005 · Genome biology
  67. HER/ErbB receptor interactions and signaling patterns in human mammary epithelial cells
    Yi Zhang, Lee K. Opresko, Harish Shankaran, William Chrisler, H. Steven Wiley, Haluk Resat · 2009 · BMC Cell Biology
  68. Discovery of AZD8931, an Equipotent, Reversible Inhibitor of Signaling by EGFR, HER2, and HER3 Receptors
    Bernard C. Barlaam, Judith Anderton, Peter G. Ballard, Robert Hart Bradbury, Laurent François Hennequin, D. Mark Hickinson, Jason G. Kettle, George G. Kirk, Teresa C. M. Klinowska, Christine Lambert‐van der Brempt et al. · 2013 · ACS Medicinal Chemistry Letters
  69. Caenorhabditis elegans: A Model System for Anti-Cancer Drug Discovery and Therapeutic Target Identification
    Robert A. Kobet, Xiaoping Pan, Baohong Zhang, Stephen C. Pak, Adam Steven Asch, Myon‐Hee Lee · 2014 · Biomolecules & Therapeutics
  70. Estrogen Receptor-α Mediates the Epidermal Growth Factor-Stimulated Prolactin Expression and Release in Lactotrophs
    Nira Ben‐Jonathan, Shenglin Chen, Joseph A. Dunckley, Christopher Ryan LaPensee, Sanjay Kansra · 2008 · Endocrinology
  71. Particle-Based Stochastic Simulation in Systems Biology
    Dominic Tölle, Nicolas Gambardella Le Novère · 2006 · Current Bioinformatics
  72. ERBB3 targeting: A promising approach to overcoming cancer therapeutic resistance
    Yutao Chen, Anni Lu, Zhangli Hu, Jinyao Li, Jun Lu · 2024 · Cancer Letters
  73. Increased Epidermal Growth Factor Receptor (EGFR) Associated with Hepatocyte Growth Factor (HGF) and Symptom Severity in Children with Autism Spectrum Disorders (ASDs)
    Anthony J. Russo · 2014 · Journal of Central Nervous System Disease
  74. A growing family: Adding mutated Erbb4 as a novel cancer target
    Udo Rudloff, Yardena Samuels · 2010 · Cell Cycle
  75. Next-generation sequencing applied to molecular diagnostics
    Rachael Natrajan, Jorge Sergio Reis-Filho · 2011 · Expert Review of Molecular Diagnostics
  76. The application of modular protein domains in proteomics
    Joshua A. Jadwin, Mari Ogiue-Ikeda, Kazuya Machida · 2012 · FEBS Letters
  77. Two‐dimensional separation of human plasma proteins using iterative free‐flow electrophoresis
    Mikkel Nissum, Sabine Kuhfuss, Monika Hauptmann, Christian Obermaier, Ute Sukop, Robert Wildgruber, Gerhard Weber, Christoph Eckerskorn, Johan A. Malmström · 2007 · PROTEOMICS
  78. Topological and Functional Properties of the Small GTPases Protein Interaction Network
    Anna Delprato · 2012 · PLoS ONE
  79. Ventricular ErbB2/ErbB4 activation and downstream signaling in pacing-induced heart failure
    Kris Doggen, Lynn Ray, Myrielle Mathieu, Kathleen Mc Entee, Katrien Lemmens, Gilles W. De Keulenaer · 2008 · Journal of Molecular and Cellular Cardiology
  80. Therapeutic targeting of EGFR-activated metabolic pathways in glioblastoma
    Qinglei Gao, Ting Lei, Fei Ye · 2013 · Expert Opinion on Investigational Drugs
  81. Automatic decomposition of kinetic models of signaling networks minimizing the retroactivity among modules
    Julio Sáez-Rodríguez, Stefan Gayer, Martin Ginkel, Ernst Dieter Gilles · 2008 · Bioinformatics
  82. Combination of radiotherapy with EGFR antagonists for head and neck carcinoma
    Juliette Thariat, Gökçen Yildirim, Kathryn A. Mason, Adam S. Garden, Luka Milas, K. Kian Ang · 2007 · International Journal of Clinical Oncology
  83. Proteomic and Bioinformatic Analysis on Endocrine Organs of Domesticated Silkworm, Bombyx mori L. for a Comprehensive Understanding of Their Roles and Relations
    Jianying Li, Xiang Chen, Wei Fan, Seyed Hossein Hosseini Moghaddam, Ming Chen, Zhonghua Zhou, Huijuan Yang, Jine Chen, Boxiong Zhong · 2009 · Journal of Proteome Research
  84. Role of Epidermal Growth Factor Receptor Signaling in the Interaction of Neisseria meningitidis with Endothelial Cells
    Heiko Slanina, Sabrina Mündlein, Sabrina Hebling, Alexandra Schubert‐Unkmeir · 2013 · Infection and Immunity
  85. Selective repression of RET proto-oncogene in medullary thyroid carcinoma by a natural alkaloid berberine
    Vishnu Muthuraj Kumarasamy, Yoon-Joo Shin, John White, Daekyu Sun · 2015 · BMC Cancer
  86. System-Level Comparison of Protein−Protein Interactions between Viruses and the Human Type I Interferon System Network
    Vincent Navratil, Benoı̂t de Chassey, Laurène Meyniel‐Schicklin, Fabrine Pradezynski, Patrice André, Chantal Rabourdin‐Combe, Vincent Lotteau · 2010 · Journal of Proteome Research
  87. C‐X‐C chemokine receptor 7
    Travis J. Yates, Judith Knapp, Miguel Gosalbez, Soum D. Lokeshwar, Christopher S. Gomez, Anaid Benitez, Obi Ekwenna, Ezekiel E. Young, Murugesan Manoharan, Vinata B. Lokeshwar · 2012 · Cancer
  88. Molecular biology of human epidermal receptors, signaling pathways and targeted therapy against cancers: new evidences and old challenges
    Paulo Michel Pinheiro Ferreira, Cláudia Pessoa · 2017 · Brazilian Journal of Pharmaceutical Sciences
  89. Integrating Radiotherapy With Epidermal Growth Factor Receptor Antagonists and Other Molecular Therapeutics for the Treatment of Head and Neck Cancer
    Juliette Thariat, Luka Milas, K. Kian Ang · 2007 · International Journal of Radiation Oncology*Biology*Physics
  90. A preliminary analysis of gene pleiotropy estimated from protein sequences
    Zhixi Su, Yanwu Zeng, Xun Gu · 2009 · Journal of Experimental Zoology Part B Molecular and Developmental Evolution
  91. Epidermal growth factor mediates spermatogonial proliferation in newt testis
    Keisuke Abé, Ko Eto, Shin‐ichi Abé · 2008 · Reproductive Biology and Endocrinology
  92. Systems Biology of AGC Kinases in Fungi
    Alex Sobko · 2006 · Science s STKE
  93. Fast computing global structural balance in signed networks based on memetic algorithm
    Yixiang Sun, Haifeng Du, Maoguo Gong, Lijia Ma, Shanfeng Wang · 2014 · Physica A Statistical Mechanics and its Applications
  94. ErbB2 Is Necessary for ErbB4 Ligands to Stimulate Oncogenic Activities in Models of Human Breast Cancer
    Christopher Peter Mill, Michael D. Zordan, Stephen Michael Rothenberg, Jeff Settleman, James F. Leary, David J. Riese · 2011 · Genes & Cancer
  95. Gene expression profile of human thyroid cancer in relation to its mutational status
    Dagmara Rusinek, Sylwia Szpak‐Ulczok, Barbara Jarząb · 2011 · Journal of Molecular Endocrinology
  96. Rule-Based Modeling of Signal Transduction: A Primer
    John A. P. Sekar, James R. Faeder · 2012 · Methods in molecular biology
  97. Phage engineering: how advances in molecular biology and synthetic biology are being utilized to enhance the therapeutic potential of bacteriophages
    Russell Brown, Andreas Lengeling, Baojun Wang · 2017 · Quantitative Biology
  98. Overexpression of secretory phospholipase A2-IIa supports cancer stem cell phenotype via HER/ERBB-elicited signaling in lung and prostate cancer cells
    Shan Lu, Zhongyun Dong · 2017 · International Journal of Oncology
  99. Emerging applications for phospho-proteomics in cancer molecular therapeutics
    Michael F. Moran, Jiefei Tong, Paul P. Taylor, Rob M. Ewing · 2006 · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer
  100. Signal Transduction Networks in Cancer: Quantitative Parameters Influence Network Topology
    David J. Klinke · 2010 · Cancer Research